Autologous Mesenchymal Stem Cell Transplantation in Multiple Sclerosis: A Meta-Analysis

Stem Cell-Derived Exosomes as Nanotherapeutics for Autoimmune and Neurodegenerative Disorders

(2019) Milad Riazifar et al.   ACS Nano

Mesenchymal stem cell mediated effects on microglial phenotype in cuprizone‐induced demyelination model

(2019) Shirin Barati et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

(2018) Ludwig Kappos et al.   LANCET

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

(2018) Raju Kapoor et al.   LANCET NEUROLOGY

Adipose-derived mesenchymal stem cells (AdMSC) for the treatment of secondary-progressive multiple sclerosis: A triple blinded, placebo controlled, randomized phase I/II safety and feasibility study

(2018) Oscar Fernández et al.   PLoS One

Phase I Trial of Intrathecal Mesenchymal Stem Cell-derived Neural Progenitors in Progressive Multiple Sclerosis

(2018) Violaine K. Harris et al.   EBioMedicine

Learning from other autoimmunities to understand targeting of B cells to control multiple sclerosis

(2018) David Baker et al.   BRAIN

Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis

(2017) Jeffrey A Cohen et al.   Multiple Sclerosis Journal

Autologous hematopoietic stem cell transplantation in multiple sclerosis

(2017) Maria Pia Sormani et al.   NEUROLOGY

Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis

(2017) Jeffrey A Cohen et al.   Multiple Sclerosis Journal

Progressive multiple sclerosis: from pathogenic mechanisms to treatment

(2016) Jorge Correale et al.   BRAIN

Clinical safety of intrathecal administration of mesenchymal stromal cell–derived neural progenitors in multiple sclerosis

(2016) Violaine K. Harris et al.   CYTOTHERAPY

Mesenchymal Stem Cells Differentially Modulate Effector CD8+ T Cell Subsets and Exacerbate Experimental Autoimmune Encephalomyelitis

(2014) Justin D. Glenn et al.   STEM CELLS

Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation

(2013) Maria Ester Bernardo et al.   Cell Stem Cell

Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE)

(2013) Forouzan Yousefi et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept study

(2012) Peter Connick et al.   LANCET NEUROLOGY

Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: An Open Label Study

(2012) Mandana Mohyeddin Bonab et al.   Current Stem Cell Research & Therapy

Mesenchymal Stem Cells: Mechanisms of Inflammation

(2011) Nora G. Singer et al.   Annual Review of Pathology-Mechanisms of Disease

Safety and Immunological Effects of Mesenchymal Stem Cell Transplantation in Patients With Multiple Sclerosis and Amyotrophic Lateral Sclerosis

(2010) Dimitrios Karussis et al.   ARCHIVES OF NEUROLOGY

Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: A pilot study

(2010) Bassem Yamout et al.   JOURNAL OF NEUROIMMUNOLOGY

The therapeutic potential of mesenchymal stem cell transplantation as a treatment for multiple sclerosis: consensus report of the International MSCT Study Group

(2010) Mark S Freedman et al.   Multiple Sclerosis Journal

New perspectives in human stem cell therapeutic research

(2009) Alan Trounson   BMC Medicine